VOYA Investment Management’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74K Buy
+15,838
New +$65K ﹤0.01% 2397
2025
Q2
– Sell
-1,977
Closed -$14K – 2752
2025
Q1
$14K Buy
1,977
+20
+1% +$275 ﹤0.01% 2632
2024
Q4
$43.1K Hold
1,957
– – ﹤0.01% 2701
2024
Q3
$39.3K Hold
1,957
– – ﹤0.01% 2785
2024
Q2
$34K Buy
1,957
+604
+45% +$19.8K ﹤0.01% 2816
2024
Q1
$56.4K Sell
1,353
-289
-18% -$8.04K ﹤0.01% 2717
2023
Q4
$41.3K Hold
1,642
– – ﹤0.01% 2863
2023
Q3
$53.7K Hold
1,642
– – ﹤0.01% 2846
2023
Q2
$95.6K Buy
+1,642
New +$84.4K ﹤0.01% 2802

Other funds holding XFOR

VOYA Investment Management's XFOR Position: Q2 2026 in Review

VOYA Investment Management opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 15,838 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #2397 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in XFOR as recently as Q1 2025.

VOYA Investment Management first reported a position in XFOR in Q2 2023 and has held it in 9 quarters since. The position peaked at $95.6K in Q2 2023. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • VOYA Investment Management held 15,838 shares of X4 Pharmaceuticals worth $74K as of Q2 2026.
  • X4 Pharmaceuticals was a new VOYA Investment Management position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2397 holding.
  • VOYA Investment Management first reported a position in X4 Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
  • VOYA Investment Management's X4 Pharmaceuticals position peaked at $95.6K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.